Description: XVIVO is a medical technology company focused on developing optimized solutions for organ, tissue and cell preservation in connection with transplantation. Our mission is to increase the survival rates of patients awaiting transplantation by providing more effective, clinically proven innovative products that both increase the availability of acceptable donors organs and improve survival after transplantation. We are committed to provide our customers with solutions and systems that can improve the transplant process outcome, facilitate the work for the transplant team, and enhance the long-term outcomes and quality of life of the transplant recipient.
Home Page: www.xvivogroup.com
Gemenskapens gata 9
Mölndal,
431 53
Sweden
Phone:
46 3 17 88 21 50
Officers
| Name | Title |
|---|---|
| Mr. Christoffer Rosenblad | Chief Executive Officer |
| Mr. Kristoffer Nordstrom | Chief Financial Officer |
| Ms. Lena Hagman B.Sc. | COO & Deputy CEO |
| Mr. Andreas Wallinder M.D., Ph.D. | Chief Medical Officer |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 86.2069 |
|---|---|
| Trailing PE: | 71.5 |
| Price-to-Book MRQ: | 7.1162 |
| Price-to-Sales TTM: | 1.8004 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 161 |